474
Participants
Start Date
October 17, 2019
Primary Completion Date
September 14, 2021
Study Completion Date
September 14, 2021
Antivenom serum Inoserp Pan-Africa® injection
Participation to the study does not change usual follow-up of patients. All medical procedures will be performed and products will be used in a routine manner. Antivenom serum Inoserp Pan-Africa® injection will be decided according to the clinical evaluation of the patient.
Hôpital de District d'Akonolinga, Akonolinga
Hôpital régional de Buea, Buea
Hôpital de District de Guider, Guider
Hôpital de District de Kolofata, Kolofata
Hôpital Régional de Limbe, Limbe
Hôpital de District de Mora, Mora
Hôpital Norvégien de N'Gaoundéré, N'Gaoundéré
Hôpital Régional de N'Gaoundéré, N'Gaoundéré
Hôpital Saint Malte de Njombe, Njombé
Hôpital de District de Poli, Poli
Hôpital de District de Sa'a, Sa'a
Hôpital de District de Tokombere, Tokonbéré
Centre des Urgences de Yaounde (CURY), Yaoundé
Lead Sponsor
Collaborators (1)
Cameroon Society of Epidemiology (CaSE)
UNKNOWN
Centre International de Recherches d'Enseignements et de Soins (CIRES)
UNKNOWN
Centre Pasteur du Cameroun
OTHER
Inosan Biopharma
INDUSTRY
Institut Pasteur
INDUSTRY